SCHEDULE 13G/A: Ayrton Capital and Affiliates Disclose 6.2% Beneficial Ownership in SeaStar Medical Holding Corp.

Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri have filed an amended Schedule 13G, disclosing a collective beneficial ownership of 6.2% in SeaStar Medical Holding Corp.'s common stock as of December 31, 2024.

Summary

• Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G.
• The Reporting Persons collectively beneficially own 294,361 shares of SeaStar Medical Holding Corp. (the "Issuer") common stock.
• This ownership represents 6.2% of the Issuer's common stock class.
• The 294,361 shares are issuable upon the exercise of certain warrants held by the Reporting Persons.
• These issuable shares are subject to a 9.99% beneficial ownership blocker.
• The percentage of class is calculated based on 4,463,148 shares of common stock outstanding as of November 6, 2024, plus the 294,361 shares issuable from warrants.
• Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, a Cayman Islands exempted company, holds the shares.
• Ayrton Capital LLC, a Delaware limited liability company, serves as the investment manager for Alto Opportunity Master Fund.
• Waqas Khatri serves as the managing member of Ayrton Capital LLC and is also a director of Alto Opportunity Master Fund.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the Issuer.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of beneficial ownership, providing no direct operational or financial performance details of the company. It simply reports an investor's stake.

Positives

• The filing indicates a significant beneficial ownership stake (6.2%) by institutional and individual investors, which can be viewed as a vote of confidence in SeaStar Medical Holding Corp.
• The shares are derived from warrants, suggesting a prior investment commitment to the company.

Negatives

• The document does not contain any negative information regarding SeaStar Medical Holding Corp.'s operational performance or financial health.

Risks

• No specific risks related to SeaStar Medical Holding Corp.'s operations, financial health, or strategic direction are disclosed in this beneficial ownership filing.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant beneficial ownership stake by institutional investors may be viewed positively, indicating investor confidence and potentially attracting further investment interest.

Key Dates

Keywords

SeaStar Medical Holding Corp., Ayrton Capital LLC, Alto Opportunity Master Fund, Waqas Khatri, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Warrants, Investment Management, Institutional Investor